Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Is a
Allocation Type
Randomized
0
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Interventional Trial Phase
Phase 3
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Plozasiran Injection
0
Placebo
0
Intervention Type
Drug
0
Last Updated
April 4, 2024
0
Masked Party
Participant
0
Outcomes Assessor
0
Investigator
0
Care Provider
0
Masking Type
Quadruple
0
Primary Completion Date
2026
0
Trial Recruitment Size
1,328
0
Trial Sponsor
Clinical Trial Start Date
2024
0
Study Completion Date
2026
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Hypertriglyceridemia
0
Official Website
Find more entities like Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.